Patents by Inventor Zachary Yim

Zachary Yim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY
    Publication number: 20170007569
    Abstract: The present invention provides stable pharmaceutical compositions of poorly water soluble pharmaceutical agents and stabilizing agents which function to increase stability of the compositions. The use of stabilizing agents provide extended stability of nanoparticle suspensions and other formulations of poorly water soluble pharmaceutical agents such as docetaxel under certain conditions, for example upon dilution for administration.
    Type: Application
    Filed: June 9, 2016
    Publication date: January 12, 2017
    Inventors: Tapas DE, Neil P. DESAI, Andrew YANG, Zachary YIM, Patrick SOON-SHIONG
  • Compositions and methods for preparation of poorly water soluble drugs with increased stability
    Patent number: 9308180
    Abstract: The present invention provides stable pharmaceutical compositions of poorly water soluble pharmaceutical agents and stabilizing agents which function to increase stability of the compositions. The use of stabilizing agents provide extended stability of nanoparticle suspensions and other formulations of poorly water soluble pharmaceutical agents such as docetaxel under certain conditions, for example upon dilution for administration.
    Type: Grant
    Filed: February 29, 2012
    Date of Patent: April 12, 2016
    Assignee: Abraxis BioScience, LLC
    Inventors: Tapas De, Neil P Desai, Andrew Yang, Zachary Yim, Patrick Soon-Shiong
  • COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY
    Publication number: 20120308612
    Abstract: The present invention provides stable pharmaceutical compositions of poorly water soluble pharmaceutical agents and stabilizing agents which function to increase stability of the compositions. The use of stabilizing agents provide extended stability of nanoparticle suspensions and other formulations of poorly water soluble pharmaceutical agents such as docetaxel under certain conditions, for example upon dilution for administration.
    Type: Application
    Filed: February 29, 2012
    Publication date: December 6, 2012
    Inventors: Tapas DE, Neil P. DESAI, Andrew YANG, Zachary YIM, Patrick SOON-SHIONG
  • Compositions and methods for preparation of poorly water soluble drugs with increased stability
    Patent number: 8034765
    Abstract: The present invention provides stable pharmaceutical compositions of poorly water soluble pharmaceutical agents and stabilizing agents which function to increase stability of the compositions. The use of stabilizing agents provide extended stability of nanoparticle suspensions and other formulations of poorly water soluble pharmaceutical agents such as docetaxel under certain conditions, for example upon dilution for administration.
    Type: Grant
    Filed: August 30, 2006
    Date of Patent: October 11, 2011
    Assignee: Abraxis BioScience, LLC
    Inventors: Tapas De, Neil P. Desai, Andrew Yang, Zachary Yim, Patrick Soon-Shiong
  • COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY
    Publication number: 20110196026
    Abstract: The present invention provides stable pharmaceutical compositions of poorly water soluble pharmaceutical agents and stabilizing agents which function to increase stability of the compositions. The use of stabilizing agents provide extended stability of nanoparticle suspensions and other formulations of poorly water soluble pharmaceutical agents such as docetaxel under certain conditions, for example upon dilution for administration.
    Type: Application
    Filed: September 2, 2010
    Publication date: August 11, 2011
    Applicant: Abraxis BioScience, Inc.
    Inventors: Tapas De, Neil P. Desai, Andrew Yang, Zachary Yim, Patrick Soon-Shiong
  • Compositions and methods for preparation of poorly water soluble drugs with increased stability
    Patent number: 7981445
    Abstract: The present invention provides stable pharmaceutical compositions of poorly water soluble pharmaceutical agents and stabilizing agents which function to increase stability of the compositions. The use of stabilizing agents provide extended stability of nanoparticle suspensions and other formulations of poorly water soluble pharmaceutical agents such as docetaxel under certain conditions, for example upon dilution for administration.
    Type: Grant
    Filed: March 11, 2009
    Date of Patent: July 19, 2011
    Assignee: Abraxis Bioscience, LLC
    Inventors: Tapas De, Neil P. Desai, Andrew Yang, Zachary Yim, Patrick Soon-Shiong
  • COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY
    Publication number: 20110118342
    Abstract: The present invention provides stable pharmaceutical compositions of poorly water soluble pharmaceutical agents and stabilizing agents which function to increase stability of the compositions. The use of stabilizing agents provide extended stability of nanoparticle suspensions and other formulations of poorly water soluble pharmaceutical agents such as docetaxel under certain conditions, for example upon dilution for administration.
    Type: Application
    Filed: June 17, 2010
    Publication date: May 19, 2011
    Inventors: Tapas De, Neil P. Desai, Andrew Yang, Zachary Yim, Patrick Soon-Shiong
  • COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY
    Publication number: 20090196933
    Abstract: The present invention provides stable pharmaceutical compositions of poorly water soluble pharmaceutical agents and stabilizing agents which function to increase stability of the compositions. The use of stabilizing agents provide extended stability of nanoparticle suspensions and other formulations of poorly water soluble pharmaceutical agents such as docetaxel under certain conditions, for example upon dilution for administration.
    Type: Application
    Filed: March 11, 2009
    Publication date: August 6, 2009
    Inventors: Tapas De, Neil P. Desai, Andrew Yang, Zachary Yim, Patrick Soon-Shiong
  • Compositions and methods for preparation of poorly water soluble drugs with increased stability
    Publication number: 20070082838
    Abstract: The present invention provides stable pharmaceutical compositions of poorly water soluble pharmaceutical agents and stabilizing agents which function to increase stability of the compositions. The use of stabilizing agents provide extended stability of nanoparticle suspensions and other formulations of poorly water soluble pharmaceutical agents such as docetaxel under certain conditions, for example upon dilution for administration.
    Type: Application
    Filed: August 30, 2006
    Publication date: April 12, 2007
    Applicant: Abraxis BioScience, Inc.
    Inventors: Tapas De, Neil Desai, Andrew Yang, Zachary Yim, Patrick Soon-Shiong, Brian Ross, Alnawaz Rehemthlla
  • Methods of preventing and treating alimentary mucositis
    Publication number: 20050256042
    Abstract: The present invention relates to compositions and methods for preventing and treating alimentary mucositis. More particularly, the present invention provides methods for preventing and/or treating alimetary mucositis by using compositions comprising FGF-20, a fragment, a derivative, a variant, a homolog, or an analog thereof.
    Type: Application
    Filed: November 3, 2004
    Publication date: November 17, 2005
    Inventors: Michael Jeffers, Zachary Yim, Pascal Valax, Pradyumna Namdev, Rajeev Chillakuru, William LaRochelle, Henri Lichenstein, Enrique Alvarez, William Hahne
  • Compositions and methods of use for a fibroblast growth factor
    Publication number: 20040214759
    Abstract: In methods of using a fibroblast growth factor, such as for treating, preventing or delaying a proliferation-associated disorder, steps are provided to administer to a subject a therapeutically effective amount of a particular fibroblast growth factor polypeptide, or variant or fragment thereof.
    Type: Application
    Filed: May 9, 2003
    Publication date: October 28, 2004
    Inventors: John P. Alsobrook, Enrique Alvarez, David W. Anderson, Joel S. Bader, Ferenc L. Boldog, Catherine E. Burgess, Rajeev A. Chillakuru, Lisa Deegler, Shlomit R. Edinger, Elma R. Fernandes, Linda Gorman, William M. Grosse, John L. Herrmann, Michael E. Jeffers, William J. LaRochelle, Denise M. Lepley, Henri S. Lichenstein, Kumar Namdev, Muralidhara Padigaru, Carol E. A. Pena, Sudhirdas K. Prayaga, Daniel K. Rieger, Richard A. Shimkets, Pascal Valax, Meijia Yang, Zachary Yim, Mei Zhong
  • Therapeutic antiangiogenic compositions and methods
    Publication number: 20040091465
    Abstract: An inhibitor of endothelial cell proliferation, capable of inhibiting angiogenesis and causing tumor regression, that is approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII, and methods of treating angiogenesis-related disease are provided. The inhibitor is known as endostatin. In a preferred embodiment, endostatin is administered to a patient in a pharmaceutical formulation. The pharmaceutical formulation preferably comprises endostatin combined with sucrose octasulfate.
    Type: Application
    Filed: June 26, 2003
    Publication date: May 13, 2004
    Inventor: Zachary Yim
  • Insoluble copper-alpha interferon complex
    Patent number: 4871538
    Abstract: An insoluble copper-alpha interferon complex useful for injectable pharmaceutical compositions is disclosed.
    Type: Grant
    Filed: July 13, 1987
    Date of Patent: October 3, 1989
    Assignee: Schering Corporation
    Inventors: Zachary Yim, Martin Zupon, Imtiaz Chaudry
  • Zinc-protamine-alpha interferon complex
    Patent number: 4853218
    Abstract: An insoluble zinc-protamine alpha interferon complex useful as an injectable sustained release dosage form for administering alpha interferon is disclosed.
    Type: Grant
    Filed: February 24, 1987
    Date of Patent: August 1, 1989
    Assignee: Schering Corporation
    Inventors: Zachary Yim, Michael A. Zupon, Imtiaz A. Chaudry
  • Stable oleaginous gel
    Patent number: 4851220
    Abstract: Stable oleaginous gels comprising water-in-oil emulsions in gels are disclosed. Sustained release injectable pharmaceutical formulations comprising such oleaginous gels are also disclosed, in particular such formulations comprising interferon.
    Type: Grant
    Filed: November 26, 1986
    Date of Patent: July 25, 1989
    Assignee: Schering Corporation
    Inventors: Zachary Yim, Michael A. Zupon, Imtiaz A. Chaudry